Health Care: Drugs

Arqule Inc. (ARQL: NASDAQ)

$2.36 -0.07 | -2.88%
06/19/13 - 04:00 PM ET
Company Income Statement
Dec 2012 Dec 2011 Dec 2010 Dec 2009
Sales 36.41M 47.31M 29.22M 25.20M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 36.41M 47.31M 29.22M 25.20M
Selling, General, and Administrative Expenses 13.85M 13.37M 13.48M 13.32M
Research & Development 33.97M 45.01M 47.03M 49.50M
Operating Income before D & A (EBITDA) -11.40M -11.07M -31.29M -37.61M
Depreciation & Amortization 2.38M 1.74M 2.56M 2.61M
Interest Income 445.00K 317.00K 619.00K 1.09M
Other Income - Net 113.00K 20.00K 266.00K 1.59M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -13.23M -12.47M -32.96M -37.54M
Interest Expense 26.00K 25.00K 274.00K 655.00K
Pre-Tax Income -13.26M -12.50M -33.23M -38.20M
Income Taxes 0.00 0.00 -550.00K 550.00K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -10.87M 0.00 0.00 0.00
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -10.87M 0.00 0.00 0.00
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -10.87M -10.76M -30.13M -36.14M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-10.87M 0.00 0.00 0.00
Preferred Dividends
Net Income Available To Common -10.87M 0.00 0.00 0.00
Basic EPS from Continuing Ops. -0.18 -0.20 -0.68 -0.82
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.18 -0.20 -0.68 -0.82
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.18 -0.20 -0.68 -0.82
Basic Normalized Net Income/Share -0.18 n.a. n.a. n.a.
EPS fr Continuing Ops. -0.18 -0.20 -0.68 -0.82
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.18 -0.20 -0.68 -0.82
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.18 -0.20 -0.68 -0.82
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.18 n.a. n.a. n.a.
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ARQL

Latest ARQL Headlines from TheStreet

More Financial News for ARQL

Press Releases for ARQL

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter